Veru said Monday that its investigational drug helped preserve lean mass in patients taking the obesity treatment Wegovy, though some experts were skeptical that the topline results were adequate ...

On December 19, 2024, FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly is tirzepatide’s patentholder and the ...

Novo Nordisk), semaglutide (Wegovy, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly) for the treatment of diabetes or obesity that reported on changes in fat mass, lean mass or bone mineral ...

On Friday morning, Novo Nordisk unveiled the latest results from a clinical trial of CagriSema, an investigational drug leveraging the foundational semaglutide molecule used in Wegovy ...

We will focus on telehealth companies, like Jack & Jill, that offer Ozempic alternatives over the counter, such as compounded semaglutide and tirzepatide, as well as top FDA-approved weight loss ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Clothing brands are among the businesses benefiting from the GLP-1 boom as users treat their slimmer selves Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy ...

You’ve got Wegovy that’s approved for weight loss, but it’s not approved for the treatment of diabetes. Eli Lilly then came up with a second-generation drug and they named it tirzepatide.

Eli Lilly has raised its revenue guidance for 2024 by $3 billion, after reporting strong growth for tirzepatide in diabetes ... Ozempic for diabetes and Wegovy for obesity – for the first ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

It remains to be seen if that approach is better. Like Wegovy, tirzepatide is also dosed weekly, so AMG 133 could provide an option that requires fewer injections if its once-monthly dosing ...